Monoamine oxidase inhibitors (MAOI) might inhibit barbiturate metabolism and extend barbiturate consequences; watch carefully pentobarbital will lower the level or influence of acalabrutinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. The warning indications